{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:03:54Z","timestamp":1753182234614,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DGM: Deutsche Gesellschaft f\u00fcr Muskelkranke"},{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by mutations in the SMN gene, leading to progressive muscular weakness, atrophy and so far neglected musculoskeletal pain. This study is the first to characterize nociceptive pain in patients living with SMA type 3 by assessing whether muscle pain is associated with alterations in muscle strength, function, stiffness, frequency, decrement, relaxation, or creep.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a cross-sectional pilot study on 20 SMA3 patients. We evaluated motor function and muscle strength (dynamometry, quick motor function test and 6-min-walk test), nociceptive pain (pressure algometer evaluating muscular pressure pain threshold (PPT)) and non-invasive measurement of muscle stiffness, frequency, decrement, relaxation, or creep (myotonometry with the MyotonPro<jats:sup>\u00ae<\/jats:sup>). For statistical analysis, we used <jats:italic>t<\/jats:italic> tests, Mann\u2013Whitney <jats:italic>U<\/jats:italic> tests and linear regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Significantly more women than men reported musculoskeletal pain (<jats:italic>p<\/jats:italic>\u2009=\u20090.003). A lower score in dynamometry was associated with lower scores in PPT in all extremities reflecting a higher sensitivity of these muscles to pressure. We did not find significant correlations between the PPT values and the MyotonPro values in the corresponding muscles. Assessments of PPT before and after the 6-min walk test did not show clinical meaningful changes. Besides nociceptive pain, fatigue was prevalent in 50% and pain in 55% of the patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Muscle pain in SMA3 is associated with muscular weakness in the arms and legs, but not with changes in muscular stiffness, frequency, decrement, relaxation, or creep. This shows that muscle pain in SMA3 is mainly caused by changes in the dysbalanced musculoskeletal system due to muscle weakness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-022-11351-0","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T10:03:38Z","timestamp":1661767418000},"page":"250-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nociceptive pain in adult patients with 5q-spinal muscular atrophy type 3: a cross-sectional clinical study"],"prefix":"10.1007","volume":"270","author":[{"given":"Elena","family":"Sagerer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Wirner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2757-8131","authenticated-orcid":false,"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8407-3642","authenticated-orcid":false,"given":"Stephan","family":"Wenninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"11351_CR1","doi-asserted-by":"publisher","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines\nfor the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111\u2013117. https:\/\/doi.org\/10.1164\/ajrccm.166.1.at1102. Erratum in: Am J Respir Crit Care Med. 2016;193(10):1185. PMID: 12091180","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"11351_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/104990910201900109","volume":"19","author":"RT Abresch","year":"2002","unstructured":"Abresch RT, Carter GT, Jensen MP, Kilmer DD (2002) Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care 19:39\u201348","journal-title":"Am J Hosp Palliat Care"},{"key":"11351_CR3","doi-asserted-by":"crossref","unstructured":"Compston A (2010) Aids to the Investigation of Peripheral Nerve Injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with Aids to the Examination of the Peripheral Nervous System. By Michael O\u2019Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures. Brain 133:2838\u20132844","DOI":"10.1093\/brain\/awq270"},{"key":"11351_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","volume":"6","author":"A D'Amico","year":"2011","unstructured":"D\u2019Amico A, Mercuri E, Tiziano FD, Bertini E (2011) Spinal muscular atrophy. Orphanet J Rare Dis 6:71\u201371","journal-title":"Orphanet J Rare Dis"},{"key":"11351_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/16501970510030156","volume":"37","author":"IJ de Groot","year":"2005","unstructured":"de Groot IJ, de Witte LP (2005) Physical complaints in ageing persons with spinal muscular atrophy. J Rehabil Med 37:258\u2013262","journal-title":"J Rehabil Med"},{"key":"11351_CR6","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.nmd.2013.06.370","volume":"23","author":"IJ de Groot","year":"2013","unstructured":"de Groot IJ, Voet NB, van Middendorp H, Knoop H, Rahbek J, van Engelen BG (2013) 184th ENMC international workshop: pain and fatigue in neuromuscular disorders: 20\u201322 May 2011, Naarden, The Netherlands. Neuromuscul Disord 23:1028\u20131032","journal-title":"Neuromuscul Disord"},{"key":"11351_CR7","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga CA, Saito K, Servais L, Tizzano E, Topaloglu H, Tulinius M, Montes J, Glanzman AM, Bishop K, Zhong ZJ, Gheuens S, Bennett CF, Schneider E, Farwell W, De Vivo DC (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723\u20131732","journal-title":"N Engl J Med"},{"key":"11351_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00415-006-0434-2","volume":"254","author":"MLC Hagemans","year":"2007","unstructured":"Hagemans MLC, van Schie SPM, Janssens ACJW, van Doorn PA, Reuser AJJ, van der Ploeg AT (2007) Fatigue: an important feature of late-onset Pompe disease. J Neurol 254:941\u2013945","journal-title":"J Neurol"},{"key":"11351_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121\u20131123","journal-title":"Arch Neurol"},{"issue":"5","key":"11351_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ejpn.2015.04.005","volume":"19","author":"C Lager","year":"2015","unstructured":"Lager C, Kroksmark A (2015) Pain in adolescents with spinal muscular atrophy and Duchenne and Becker muscular dystrophy. Eur J Paediatr Neurol 19(5):537\u2013546","journal-title":"Eur J Paediatr Neurol"},{"key":"11351_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165","journal-title":"Cell"},{"key":"11351_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, Vitale M, Snyder B, Quijano-Roy S, Bertini E, Davis RH, Meyer OH, Simonds AK, Schroth MK, Graham RJ, Kirschner J, Iannaccone ST, Crawford TO, Woods S, Qian Y, Sejersen T (2018) Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 28:103\u2013115","journal-title":"Neuromuscul Disord"},{"key":"11351_CR13","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/jcm9072222","volume":"9","author":"S Messina","year":"2020","unstructured":"Messina S, Sframeli M (2020) New treatments in spinal muscular atrophy: positive results and new challenges. J Clin Med 9:2222","journal-title":"J Clin Med"},{"key":"11351_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00482-002-0162-1","volume":"16","author":"B Nagel","year":"2002","unstructured":"Nagel B, Gerbershagen HU, Lindena G, Pfingsten M (2002) Development and evaluation of the multidimensional German pain questionnaire. Schmerz 16:263\u2013270","journal-title":"Schmerz"},{"key":"11351_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00482-015-0019-z","volume":"29","author":"P Nilges","year":"2015","unstructured":"Nilges P, Essau C (2015) Depression, anxiety and stress scales: DASS\u2014a screening procedure not only for pain patients. Schmerz 29:649\u2013657","journal-title":"Schmerz"},{"key":"11351_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jphys.2015.07.001","volume":"62","author":"N Poquet","year":"2016","unstructured":"Poquet N, Lin C (2016) The brief pain inventory (BPI). J Physiother 62:52","journal-title":"J Physiother"},{"key":"11351_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1177\/0883073807305668","volume":"22","author":"TW Prior","year":"2007","unstructured":"Prior TW (2007) Spinal muscular atrophy diagnostics. J Child Neurol 22:952\u2013956","journal-title":"J Child Neurol"},{"key":"11351_CR18","unstructured":"Prior TW, Leach ME, Finanger E (2000) Spinal Muscular Atrophy. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) GeneReviews(\u00ae). University of Washington, Seattle (WA)"},{"key":"11351_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00482-009-0864-8","volume":"24","author":"S Schroeder","year":"2010","unstructured":"Schroeder S, Hechler T, Denecke H, M\u00fcller-Busch M, Martin A, Menke A, Zernikow B (2010) Deutscher Schmerzfragebogen f\u00fcr Kinder, Jugendliche und deren Eltern (DSF-KJ). Der Schmerz 24:23\u201337","journal-title":"Der Schmerz"},{"key":"11351_CR20","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/mds.27461","volume":"33","author":"M Siciliano","year":"2018","unstructured":"Siciliano M, Trojano L, Santangelo G, Micco R, Tedeschi G, Tessitore A (2018) Fatigue in Parkinson\u2019s disease: a systematic review and meta-analysis: fatigue in Parkinson\u2019s disease. Mov Disord 33:1712\u20131723","journal-title":"Mov Disord"},{"key":"11351_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","volume":"106","author":"DC Turk","year":"2003","unstructured":"Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J (2003) Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 106:337\u2013345","journal-title":"Pain"},{"key":"11351_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10545-011-9388-3","volume":"35","author":"CI van Capelle","year":"2012","unstructured":"van Capelle CI, van der Beek NAME, de Vries JM, van Doorn PA, Duivenvoorden HJ, Leshner RT, Hagemans MLC, van der Ploeg AT (2012) The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients. J Inherit Metab Dis 35:317\u2013323","journal-title":"J Inherit Metab Dis"},{"key":"11351_CR23","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s11136-013-0565-8","volume":"23","author":"U Werlauff","year":"2014","unstructured":"Werlauff U, H\u00f8jberg A, Firla-Holme R, Steffensen BF, Vissing J (2014) Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale. Qual Life Res 23:1479\u20131488","journal-title":"Qual Life Res"},{"key":"11351_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B (2000) An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 15:228\u2013237","journal-title":"Hum Mutat"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11351-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11351-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11351-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:17:19Z","timestamp":1672852639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11351-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["11351"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11351-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors report no disclosures regarding this study. Outside of this context, SW has received research grant by the DGM\u2014Deutsche Gesellschaft f\u00fcr Muskelkranke e.V. He has served on advisory boards for Alexion Pharma, CSL Behring and Sanofi Genzyme GmbH. He received funding for travel or speaker Honoraria from Sanofi-Aventis Germany GmbH; SH Glykogenose Gesellschaft; AbbVie Germany GmbH; Recordati Pharma GmbH; CSLBehring GmbH; Alexion Pharma GmbH; Desitin Germany; Akcea GmbH. Outside of this context, BS has served on advisory boards for Alexion, Argenex, Amicus, Astellas, Spark, and Sanofi; he has undertaken contracted unrestricted research for Sanofi and Amicus; and has received honoraria from Kedrion. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the ethics committee of the LMU Klinikum, Project No. 20\u20130980, and the protocol was registered on a public clinical trials registry (ClinicalTrials.gov Identifier NCT04907162).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}